RxDoctor Payments Data

Carter Tallman, MD

Rheumatology · Springfield, MANPI 1760479075

Payments from drug & device makers

No general payments reported

No drug or device maker reported general payments to this provider for 2019–2025. That is a common and unremarkable result.

How this compares

$0 in reported general payments places this provider in the 15th percentile of 265 rheumatology providers in Massachusetts.

See all rheumatology providers in Massachusetts

Medicare billing

Part B allowed, 2024
$877,439
Medicare patients
615
Services billed
60,548

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Enbrel SureclickEtanercept165$1,240,512
Humira(Cf) PenAdalimumab127$959,194
Humira PenAdalimumab54$465,792
EnbrelEtanercept58$463,322
Orencia ClickjectAbatacept43$245,136
OtezlaApremilast34$164,718
OrenciaAbatacept22$156,671
XeljanzTofacitinib Citrate24$136,587
Enbrel MiniEtanercept19$134,127
Humira(Cf)Adalimumab18$132,972
Cosentyx Sensoready PenSecukinumab14$126,428
Cosentyx Sensoready (2 Pens)Secukinumab16$121,156
KevzaraSarilumab26$114,066
SimponiGolimumab18$106,085
Xeljanz XrTofacitinib Citrate14$78,557

Paid to pharmacies, not to this prescriber.

Other rheumatology in Springfield

See the full list for Massachusetts

Where these figures come from

Is this you, or does something look wrong? →